Effectiveness and tolerance of clobazam in temporal lobe epilepsy

G. Barcs, P. Halász

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Introduction - The main objective of this retrospective study was the further exploration of the loss of efficiency of the clobazam therapy (CLOB tolerance) in resistant temporal lobe epilepsy (TLE). Material and methods - For up to 42 months we closely followed the state of 55 TLE patients placed on CLOB as an add-on therapy. Also, we sought for a connection between CLOB tolerance and clinical characteristics. Results - by the end of the 1st month 71% of the patients were seizure-free; 20% improved; 3% relapsed totally and 6% did not respond at all. After 24 months 15% were seizure-free, 11% maintained the original improved state, 36% relapsed totally and 32% partially - which remained unchanged thereafter. Long-term efficiency was in inverse proportion to the pretreatment interictal spike activity. No significant cross-tolerance was noted between CLOB and clonazepam. Conclusion - Although the problem of CLOB tolerance is hardly overestimated, the use of CLOB in the treatment of TLE deserves consideration - despite the possibilities new drugs offer.

Original languageEnglish
Pages (from-to)88-93
Number of pages6
JournalActa Neurologica Scandinavica
Volume93
Issue number2-3
Publication statusPublished - 1996

Fingerprint

Temporal Lobe Epilepsy
Seizures
Clonazepam
Therapeutics
Retrospective Studies
Pharmaceutical Preparations
clobazam

Keywords

  • Clobazam therapy
  • Temporal lobe epilepsy
  • Tolerance

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Effectiveness and tolerance of clobazam in temporal lobe epilepsy. / Barcs, G.; Halász, P.

In: Acta Neurologica Scandinavica, Vol. 93, No. 2-3, 1996, p. 88-93.

Research output: Contribution to journalArticle

@article{ed23c0f9f16448248633d0cc355c4d2c,
title = "Effectiveness and tolerance of clobazam in temporal lobe epilepsy",
abstract = "Introduction - The main objective of this retrospective study was the further exploration of the loss of efficiency of the clobazam therapy (CLOB tolerance) in resistant temporal lobe epilepsy (TLE). Material and methods - For up to 42 months we closely followed the state of 55 TLE patients placed on CLOB as an add-on therapy. Also, we sought for a connection between CLOB tolerance and clinical characteristics. Results - by the end of the 1st month 71{\%} of the patients were seizure-free; 20{\%} improved; 3{\%} relapsed totally and 6{\%} did not respond at all. After 24 months 15{\%} were seizure-free, 11{\%} maintained the original improved state, 36{\%} relapsed totally and 32{\%} partially - which remained unchanged thereafter. Long-term efficiency was in inverse proportion to the pretreatment interictal spike activity. No significant cross-tolerance was noted between CLOB and clonazepam. Conclusion - Although the problem of CLOB tolerance is hardly overestimated, the use of CLOB in the treatment of TLE deserves consideration - despite the possibilities new drugs offer.",
keywords = "Clobazam therapy, Temporal lobe epilepsy, Tolerance",
author = "G. Barcs and P. Hal{\'a}sz",
year = "1996",
language = "English",
volume = "93",
pages = "88--93",
journal = "Acta Neurologica Scandinavica",
issn = "0001-6314",
publisher = "Wiley-Blackwell",
number = "2-3",

}

TY - JOUR

T1 - Effectiveness and tolerance of clobazam in temporal lobe epilepsy

AU - Barcs, G.

AU - Halász, P.

PY - 1996

Y1 - 1996

N2 - Introduction - The main objective of this retrospective study was the further exploration of the loss of efficiency of the clobazam therapy (CLOB tolerance) in resistant temporal lobe epilepsy (TLE). Material and methods - For up to 42 months we closely followed the state of 55 TLE patients placed on CLOB as an add-on therapy. Also, we sought for a connection between CLOB tolerance and clinical characteristics. Results - by the end of the 1st month 71% of the patients were seizure-free; 20% improved; 3% relapsed totally and 6% did not respond at all. After 24 months 15% were seizure-free, 11% maintained the original improved state, 36% relapsed totally and 32% partially - which remained unchanged thereafter. Long-term efficiency was in inverse proportion to the pretreatment interictal spike activity. No significant cross-tolerance was noted between CLOB and clonazepam. Conclusion - Although the problem of CLOB tolerance is hardly overestimated, the use of CLOB in the treatment of TLE deserves consideration - despite the possibilities new drugs offer.

AB - Introduction - The main objective of this retrospective study was the further exploration of the loss of efficiency of the clobazam therapy (CLOB tolerance) in resistant temporal lobe epilepsy (TLE). Material and methods - For up to 42 months we closely followed the state of 55 TLE patients placed on CLOB as an add-on therapy. Also, we sought for a connection between CLOB tolerance and clinical characteristics. Results - by the end of the 1st month 71% of the patients were seizure-free; 20% improved; 3% relapsed totally and 6% did not respond at all. After 24 months 15% were seizure-free, 11% maintained the original improved state, 36% relapsed totally and 32% partially - which remained unchanged thereafter. Long-term efficiency was in inverse proportion to the pretreatment interictal spike activity. No significant cross-tolerance was noted between CLOB and clonazepam. Conclusion - Although the problem of CLOB tolerance is hardly overestimated, the use of CLOB in the treatment of TLE deserves consideration - despite the possibilities new drugs offer.

KW - Clobazam therapy

KW - Temporal lobe epilepsy

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=0029983849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029983849&partnerID=8YFLogxK

M3 - Article

C2 - 8741124

AN - SCOPUS:0029983849

VL - 93

SP - 88

EP - 93

JO - Acta Neurologica Scandinavica

JF - Acta Neurologica Scandinavica

SN - 0001-6314

IS - 2-3

ER -